Rekombinanter CEACAM5 (Labetuzumab Biosimilar) Antikörper

Produktnummer ABIN7093054

Produktdetails anti-CEACAM5 (Labetuzumab Biosimilar) Antikörper

Target: CEACAM5 (Labetuzumab Biosimilar)

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Humanized

Klonalität: Monoklonal

Konjugat: Dieser CEACAM5 (Labetuzumab Biosimilar) Antikörper ist unkonjugiert

Applikation: ELISA

Verwendungszweck: Anti-CEACAM5 (labetuzumab biosimilar) mAb

Produktmerkmale: IMMU-130, hMN-14-SN-38, hMN-14-SN-38 ADC, hMN14-CL-SN-38, hMN14-SN-38

Aufreinigung: Purified from cell culture supernatant by affinity chromatography

Güteklasse: Research Grade

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: ELISA 1:5000-10000

Kommentare:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Haltbarkeit: 12 months

Details zu CEACAM5 (Labetuzumab Biosimilar)

Target: CEACAM5 (Labetuzumab Biosimilar)

Abstract: CEACAM5 (Labetuzumab Biosimilar) Produkte

Substanzklasse: Biosimilar

Hintergrund: Synonyms: CEACAM-5,CD66e,CEA,Meconium antigen 100

Gen-ID: 1048

UniProt: P06731